BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32199683)

  • 1. Protective effects of rimeporide on left ventricular function in golden retriever muscular dystrophy dogs.
    Ghaleh B; Barthélemy I; Wojcik J; Sambin L; Bizé A; Hittinger L; Tran TD; Thomé FP; Blot S; Su JB
    Int J Cardiol; 2020 Aug; 312():89-95. PubMed ID: 32199683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in Left Ventricular Contractile Function Develops in Puppies With Duchenne Muscular Dystrophy.
    Ghaleh B; Barthélemy I; Sambin L; Bizé A; Hittinger L; Blot S; Su JB
    J Am Soc Echocardiogr; 2020 Jan; 33(1):120-129.e1. PubMed ID: 31611157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilizing Ryanodine Receptors Improves Left Ventricular Function in Juvenile Dogs With Duchenne Muscular Dystrophy.
    Cazorla O; Barthélémy I; Su JB; Meli AC; Chetboul V; Scheuermann V; Gouni V; Anglerot C; Richard S; Blot S; Ghaleh B; Lacampagne A
    J Am Coll Cardiol; 2021 Dec; 78(24):2439-2453. PubMed ID: 34886965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
    Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF
    J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN
    Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin restores left ventricular function, sarcomeric protein phosphorylation, and e/nNOS levels in dogs with Duchenne muscular dystrophy cardiomyopathy.
    Su JB; Cazorla O; Blot S; Blanchard-Gutton N; Ait Mou Y; Barthélémy I; Sambin L; Sampedrano CC; Gouni V; Unterfinger Y; Aguilar P; Thibaud JL; Bizé A; Pouchelon JL; Dabiré H; Ghaleh B; Berdeaux A; Chetboul V; Lacampagne A; Hittinger L
    Cardiovasc Res; 2012 Jul; 95(1):86-96. PubMed ID: 22562664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy.
    Previtali SC; Gidaro T; Díaz-Manera J; Zambon A; Carnesecchi S; Roux-Lombard P; Spitali P; Signorelli M; Szigyarto CA; Johansson C; Gray J; Labolle D; Porte Thomé F; Pitchforth J; Domingos J; Muntoni F
    Pharmacol Res; 2020 Sep; 159():104999. PubMed ID: 32535224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy.
    Ait Mou Y; Lacampagne A; Irving T; Scheuermann V; Blot S; Ghaleh B; de Tombe PP; Cazorla O
    J Mol Cell Cardiol; 2018 Jan; 114():345-353. PubMed ID: 29275006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
    BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies.
    Yugeta N; Urasawa N; Fujii Y; Yoshimura M; Yuasa K; Wada MR; Nakura M; Shimatsu Y; Tomohiro M; Takahashi A; Machida N; Wakao Y; Nakamura A; Takeda S
    BMC Cardiovasc Disord; 2006 Dec; 6():47. PubMed ID: 17140458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Chu C; Balog-Alvarez C; Yu X; Cai JJ; Nabity M; Kornegay JN
    PLoS One; 2018; 13(3):e0194485. PubMed ID: 29554127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial and Temporal Non-Uniform Changes in Left Ventricular Myocardial Strain in Dogs with Duchenne Muscular Dystrophy.
    Ghaleh B; Barthélemy I; Sambin L; Bizé A; Corboz D; Hittinger L; Blot S; Su JB
    J Cardiovasc Dev Dis; 2023 May; 10(5):. PubMed ID: 37233184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural History of Histopathologic Changes in Cardiomyopathy of Golden Retriever Muscular Dystrophy.
    Schneider SM; Sansom GT; Guo LJ; Furuya S; Weeks BR; Kornegay JN
    Front Vet Sci; 2021; 8():759585. PubMed ID: 35252412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.
    Fraysse B; Barthélémy I; Qannari EM; Rouger K; Thorin C; Blot S; Le Guiner C; Chérel Y; Hogrel JY
    BMC Musculoskelet Disord; 2017 Apr; 18(1):153. PubMed ID: 28403854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.
    Hawkins EC; Bettis AK; Kornegay JN
    Neuromuscul Disord; 2020 Nov; 30(11):930-937. PubMed ID: 33071066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.
    Galindo CL; Soslow JH; Brinkmeyer-Langford CL; Gupte M; Smith HM; Sengsayadeth S; Sawyer DB; Benson DW; Kornegay JN; Markham LW
    Pediatr Res; 2016 Apr; 79(4):629-36. PubMed ID: 26672735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.
    Schneider SM; Sridhar V; Bettis AK; Heath-Barnett H; Balog-Alvarez CJ; Guo LJ; Johnson R; Jaques S; Vitha S; Glowcwski AC; Kornegay JN; Nghiem PP
    Mol Imaging Biol; 2018 Oct; 20(5):780-788. PubMed ID: 29508262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.
    Barthélémy I; Calmels N; Weiss RB; Tiret L; Vulin A; Wein N; Peccate C; Drougard C; Beroud C; Deburgrave N; Thibaud JL; Escriou C; Punzón I; Garcia L; Kaplan JC; Flanigan KM; Leturcq F; Blot S
    Skelet Muscle; 2020 Aug; 10(1):23. PubMed ID: 32767978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.